China NMPA Product Recall - Surgical Microscope, Ophthalmic Navigation Surgical Microscope

Carl Zeiss Meditec AG, through its subsidiary Carl Zeiss (Shanghai) Management Co., Ltd., has initiated a voluntary Level III recall concerning specific models of its Surgical Microscopes (National Medical Device Registration Certificate 20192162224) and Ophthalmic Navigation Surgical Microscopes (National Medical Device Registration Certificate 20223160461). This action falls under the regulatory oversight of the National Medical Products Administration (NMPA). The primary issue prompting this recall stems from a significant deficiency in Unique Device Identification (UDI) traceability. When these surgical microscopes are equipped with the Optical Coherence Tomography (OCT) function, the UDI system only allows for manual reporting, rather than automated or integrated tracking. This manual process complicates product lifecycle management, potentially hindering rapid identification and recall efforts should further issues arise, thus impacting patient safety and supply chain integrity. The recall documentation, made public on February 21, 2025, confirms that the specific products involved were not imported into China. As a required action, Carl Zeiss Meditec AG is undertaking this recall to address the non-compliance with UDI standards, demonstrating commitment to product quality and regulatory adherence. Companies operating under the NMPA framework are obligated to ensure comprehensive traceability, and this voluntary recall signifies the manufacturer's proactive approach in rectifying a systemic issue identified in their product design or manufacturing process related to integrated functionalities.